Real-time enrollment status for this glioblastoma (gbm) clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 5:22 PM UTC
| NCT Number | NCT07268053 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma (GBM) |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 15 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Nader Sanai |
| Last Updated on CT.gov | March 6, 2026 (Mar 6, 2026) |
As of August 30, 2026: Clinical trial NCT07268053 is currently recruiting participants. This early_phase1 study for glioblastoma (gbm) is actively seeking new participants at 1 location across the United States. The study is sponsored by Nader Sanai. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07268053 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07268053 was last updated Mar 6, 2026 (March 6, 2026). HelloStudys verifies this status automatically.